275 related articles for article (PubMed ID: 22286767)
41. Involvement of retinoblastoma family members and E2F/DP complexes in the death of neurons evoked by DNA damage.
Park DS; Morris EJ; Bremner R; Keramaris E; Padmanabhan J; Rosenbaum M; Shelanski ML; Geller HM; Greene LA
J Neurosci; 2000 May; 20(9):3104-14. PubMed ID: 10777774
[TBL] [Abstract][Full Text] [Related]
42. Role of pRb-related proteins in simian virus 40 large-T-antigen-mediated transformation.
Zalvide J; DeCaprio JA
Mol Cell Biol; 1995 Oct; 15(10):5800-10. PubMed ID: 7565733
[TBL] [Abstract][Full Text] [Related]
43. Proliferative suppression by CDK4/6 inhibition: complex function of the retinoblastoma pathway in liver tissue and hepatoma cells.
Rivadeneira DB; Mayhew CN; Thangavel C; Sotillo E; Reed CA; Graña X; Knudsen ES
Gastroenterology; 2010 May; 138(5):1920-30. PubMed ID: 20100483
[TBL] [Abstract][Full Text] [Related]
44. Melanoma cell autonomous growth: the Rb/E2F pathway.
Halaban R
Cancer Metastasis Rev; 1999; 18(3):333-43. PubMed ID: 10721488
[TBL] [Abstract][Full Text] [Related]
45. Differentiated horizontal interneurons clonally expand to form metastatic retinoblastoma in mice.
Ajioka I; Martins RA; Bayazitov IT; Donovan S; Johnson DA; Frase S; Cicero SA; Boyd K; Zakharenko SS; Dyer MA
Cell; 2007 Oct; 131(2):378-90. PubMed ID: 17956737
[TBL] [Abstract][Full Text] [Related]
46. Rb suppresses human cone-precursor-derived retinoblastoma tumours.
Xu XL; Singh HP; Wang L; Qi DL; Poulos BK; Abramson DH; Jhanwar SC; Cobrinik D
Nature; 2014 Oct; 514(7522):385-8. PubMed ID: 25252974
[TBL] [Abstract][Full Text] [Related]
47. Protection against chemotherapy-induced cytotoxicity by cyclin-dependent kinase inhibitors (CKI) in CKI-responsive cells compared with CKI-unresponsive cells.
Schmidt M; Fan Z
Oncogene; 2001 Sep; 20(43):6164-71. PubMed ID: 11593424
[TBL] [Abstract][Full Text] [Related]
48. Involvement of the STAT5-cyclin D/CDK4-pRb pathway in β-cell proliferation stimulated by prolactin during pregnancy.
Zhao X; Xu Y; Wu Y; Zhang H; Shi H; Zhu H; Woo M; Wu X
Am J Physiol Endocrinol Metab; 2019 Jan; 316(1):E135-E144. PubMed ID: 30512986
[TBL] [Abstract][Full Text] [Related]
49. Tandem E2F binding sites in the promoter of the p107 cell cycle regulator control p107 expression and its cellular functions.
Burkhart DL; Wirt SE; Zmoos AF; Kareta MS; Sage J
PLoS Genet; 2010 Jun; 6(6):e1001003. PubMed ID: 20585628
[TBL] [Abstract][Full Text] [Related]
50. Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F.
Leone G; DeGregori J; Sears R; Jakoi L; Nevins JR
Nature; 1997 May; 387(6631):422-6. PubMed ID: 9163430
[TBL] [Abstract][Full Text] [Related]
51. Changes in E2F complexes containing retinoblastoma protein family members and increased cyclin-dependent kinase inhibitor activities during terminal differentiation of cardiomyocytes.
Flink IL; Oana S; Maitra N; Bahl JJ; Morkin E
J Mol Cell Cardiol; 1998 Mar; 30(3):563-78. PubMed ID: 9515032
[TBL] [Abstract][Full Text] [Related]
52. Deregulated E2F transcriptional activity in autonomously growing melanoma cells.
Halaban R; Cheng E; Smicun Y; Germino J
J Exp Med; 2000 Mar; 191(6):1005-16. PubMed ID: 10727462
[TBL] [Abstract][Full Text] [Related]
53. Specificity of E2F1, E2F2, and E2F3 in mediating phenotypes induced by loss of Rb.
Saavedra HI; Wu L; de Bruin A; Timmers C; Rosol TJ; Weinstein M; Robinson ML; Leone G
Cell Growth Differ; 2002 May; 13(5):215-25. PubMed ID: 12065245
[TBL] [Abstract][Full Text] [Related]
54. p107 uses a p21CIP1-related domain to bind cyclin/cdk2 and regulate interactions with E2F.
Zhu L; Harlow E; Dynlacht BD
Genes Dev; 1995 Jul; 9(14):1740-52. PubMed ID: 7622038
[TBL] [Abstract][Full Text] [Related]
55. Molecular Determinants for the Inactivation of the Retinoblastoma Tumor Suppressor by the Viral Cyclin-dependent Kinase UL97.
Iwahori S; Hakki M; Chou S; Kalejta RF
J Biol Chem; 2015 Aug; 290(32):19666-80. PubMed ID: 26100623
[TBL] [Abstract][Full Text] [Related]
56. Tissue-specific tumor suppressor activity of retinoblastoma gene homologs p107 and p130.
Dannenberg JH; Schuijff L; Dekker M; van der Valk M; te Riele H
Genes Dev; 2004 Dec; 18(23):2952-62. PubMed ID: 15574596
[TBL] [Abstract][Full Text] [Related]
57. p107 is active in the nucleolus in non-dividing human granulosa lutein cells.
Green C; Chatterjee R; McGarrigle HH; Ahmed F; Thomas NS
J Mol Endocrinol; 2000 Dec; 25(3):275-86. PubMed ID: 11116207
[TBL] [Abstract][Full Text] [Related]
58. A B-myb promoter corepressor site facilitates in vivo occupation of the adjacent E2F site by p107 x E2F and p130 x E2F complexes.
Catchpole S; Tavner F; Le Cam L; Sardet C; Watson RJ
J Biol Chem; 2002 Oct; 277(41):39015-24. PubMed ID: 12147683
[TBL] [Abstract][Full Text] [Related]
59. The p107/E2F pathway regulates fibroblast growth factor 2 responsiveness in neural precursor cells.
McClellan KA; Vanderluit JL; Julian LM; Andrusiak MG; Dugal-Tessier D; Park DS; Slack RS
Mol Cell Biol; 2009 Sep; 29(17):4701-13. PubMed ID: 19564414
[TBL] [Abstract][Full Text] [Related]
60. SU9516, a cyclin-dependent kinase 2 inhibitor, promotes accumulation of high molecular weight E2F complexes in human colon carcinoma cells.
Yu B; Lane ME; Wadler S
Biochem Pharmacol; 2002 Oct; 64(7):1091-100. PubMed ID: 12234612
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
